Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
G-CSF and PRP for Recurrent Implantation Failure
NCT04411212Phase 2Unknown
- Sponsor
- Riyadh Fertility and Reproductive Health Center
- Start
- May 2020
- Primary completion
- Dec 2020
- Modality
- Cytokines & Interferons, Adoptive Cell Transfer
- Countries
- 1
01
Overview
A Phase 2 trial of filgrastim, platelet-rich plasma injection in Recurrent Implantation Failure (RIF), sponsored by Riyadh Fertility and Reproductive Health Center. Status: unknown.
02
Drugs
filgrastimplatelet-rich plasma injection
03
Conditions
Recurrent Implantation Failure (RIF)
Beyond the preview
Go deeper on NCT04411212.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04411212.